Jun. 9 at 2:42 PM
$LEXX Expecting a continued melt-up into July.
Seems like we are on the edge of a bidding war with all the activity going on.
"We are experiencing record-high levels of business development and collaboration interest in our DehydraTECH platform, even before the upcoming BIO conference," said Richard Christopher, CEO of Lexaria Bioscience. "New business relationships require intense energy and scientific evaluation from both prospective partners to discover the best fit possible. We are working tirelessly in this regard with the intent of generating positive developments that we can publicly discuss."
Although confidential information, by its nature, cannot be publicly disclosed, Lexaria's BD program has already generated a number of collaborative and potential business partnering discussions with a wide range of companies from innovative smaller biotech developers to well-known global pharmaceutical giants.
$LLY $NVO $VKTX $PFE
